Red blood cell microparticles: Clinical relevance

Transfusion Medicine and Hemotherapy

Volumn 39, Issue 5, 2012, Pages 342-347

  Rubin, Olivier ^a   Canellini, Giorgia ^a   Delobel, Julien ^a   Lion, Niels ^a   Tissot, Jean Daniel ^a  

^a Service Rgional Vaudois de Transfusion Sanguine   (Switzerland)

Author keywords

Ageing; Microparticles; Red blood cell concentrates; Red blood cells; Transfusion

Indexed keywords

AGING; BLOOD CLOTTING; BLOOD TRANSFUSION; ERYTHROCYTE; ERYTHROCYTE MICROPARTICLE; HUMAN; IMMUNOMODULATION; MEDICAL LITERATURE; REVIEW;

EID: 84866987944     PISSN: 16603796     EISSN: 16603818     Source Type: Journal    
DOI: 10.1159/000342228     Document Type: Review

References (45)

1. Diamant M, Tushuizen ME, Sturk A, Nieuwland R: Cellular microparticles: new players in the field of vascular disease? Eur J Clin Invest 2004;34:392-401.
2. Simak J, Gelderman MP: Cell membrane microparticles in blood and blood products: potentially pathogenic agents and diagnostic markers. Transfus Med Rev 2006;20:1-26.
3. Morel O, Toti F, Hugel B, Bakouboula B, Camoin-Jau L, Dignat-George F, Freyssinet JM: Procoagulant microparticles-disrupting the vascular homeostasis equation? Arterioscler Thromb Vasc Biol 2006;26:2594-2604.
4. Hugel B, Carmen M, Martinez MC, Kunzelmann C, Freyssinet JM: Membrane microparticles: two sides of the coin. Physiology 2005;20:22-27.
5. An XL, Guo XH, Sum H, Morrow J, Gratzer W, Mohandas N: Phosphatidylserine binding sites in erythroid spectrin: location and implications for membrane stability. Biochemistry 2004;43:310-315.
6. Manno S, Takakuwa Y, Mohandas N: Identification of a functional role for lipid asymmetry in biological membranes: phosphatidylserine-skeletal protein interactions modulate membrane stability. Proc Natl Acad Sci USA 2002;99:1943-1948.
7. Wolf P: Nature and significance of platelet products in human plasma. Br J Haematol 1967;13:269-288.
8. Greenwalt TJ: The how and why of exocytic vesicles. Transfusion 2006;46:143-152.
9. Schifferli JA: Microvesicles are messengers. Semin Immunopathol 2011;33:393-394.
10. VanWijk MJ, VanBavel E, Sturk A, Nieuwland R: Microparticles in cardiovascular diseases. Cardiovasc Res 2003;59:277-287.
11. Van Beers EJ, Schaap MC, Berckmans RJ, Nieuwland R, Sturk A, van Doormaal FF, Meijers JC, Biemond BJ: Circulating erythrocyte-derived microparticles are associated with coagulation activation in sickle cell disease. Haematologica 2009;94:1513-1519.
12. Rubin O, Crettaz D, Canellini G, Tissot JD, Lion N: Microparticles in stored red blood cells: an approach using flow cytometry and proteomic tools. Vox Sang 2008;95:288-297.
13. Shah MD, Bergeron AL, Dong JF, Lopez JA: Flow cytometric measurement of microparticles: pitfalls and protocol modifications. Platelets 2008;19:365-372.
14. Bosman G, Werre JM, Willekens FLA, Novotny VMJ: Erythrocyte ageing in vivo and in vitro: structural aspects and implications for transfusion. Transfus Med 2008;18:335-347.
15. Foller M, Huber SM, Lang F: Erythrocyte programmed cell death. IUBMB Life 2008;60:661-668.
16. Willekens FLA, Werre JM, Groenen-Dop YAM, Roerdinkholder-Stoelwinder B, de Pauw B, Bosman G: Erythrocyte vesiculation: a self-protective mechanism? Br J Haematol 2008;141:549-556.
17. Bosman G, Lasonder E, Luten M, Roerdinkholder-Stoelwinder B, Novotny VMJ, Bos H, De Grip WJ: The proteome of red cell membranes and vesicles during storage in blood bank conditions. Transfusion 2008;48:827-835.
18. Stewart A, Urbaniak S, Turner M, Bessos H: The application of a new quantitative assay for the monitoring of integrin-associated protein CD47 on red blood cells during storage and comparison with the expression of CD47 and phosphatidylserine with flow cytometry. Transfusion 2005;45:1496-1503.
19. Lang F, Gulbins E, Lerche H, Huber SM, Kempe DS, Foller M: Eryptosis, a window to systemic disease. Cell Physiol Biochem 2008;22:373-380.
20. Low PS, Willardson BM, Mohandas N, Rossi M, Shohet S: Contribution of the band 3-ankyrin interaction to erythrocyte-membrane mechanical stability. Blood 1991;77:1581-1586.
21. Kay MMB, Goodman SR, Sorensen K, Whitfield CF, Wong P, Zaki L, Rudloff V: Senescent cell antigen is immunologically related to band-3. Proc Natl Acad Sci USA 1983;80:1631-1635.
22. Arese P, Turrini F, Schwarzer E: Band 3/complement-mediated recognition and removal of normally senescent and pathological human erythrocytes. Cell Physiol Biochem 2005;16:133-146.
23. Kriebardis AG, Antonelou MH, Stamoulis KE, Economou-Petersen E, Margaritis LH, Papassideri IS: RBC-derived vesicles during storage: ultrastructure, protein composition, oxidation, and signaling components. Transfusion 2008;48:1943-1953.
24. Delobel J, Prudent M, Rubin O, Crettaz D, Tissot JD, Lion N: Subcellular fractionation of stored red blood cells reveals a compartment-based protein carbonylation evolution. J Proteomics 2012; DOI: 10.1016/j.prot.2012.05.004.
25. Allan D, Limbrick AR, Thomas P, Westerman MP: Release of spectrin-free spicules on reoxygenation of sickled erythrocytes. Nature 1982;295:612-613.
26. Reiter CD, Wang X, Tanus-Santos JE, Hogg N, Cannon RO 3rd, Schechter AN, Gladwin MT: Cellfree hemoglobin limits nitric oxide bioavailability in sickle-cell disease. Nat Med 2002;8:1383-1389.
27. Westerman M, Pizzey A, Hirschman J, Cerino M, Weil-Weiner Y, Ramotar P, Eze A, Lawrie A, Purdy G, Mackie I, Porter J: Microvesicles in haemoglobinopathies offer insights into mechanisms of hypercoagulability, haemolysis and the effects of therapy. Br J Haematol 2008;142:126-135.
28. Horne MK 3rd, Cullinane AM, Merryman PK, Hoddeson EK: The effect of red blood cells on thrombin generation. Br J Haematol 2006;133:403-408.
29. Kato GJ, McGowan V, Machado RF, Little JA, Taylor Jt, Morris CR, Nichols JS, Wang X, Poljakovic M, Morris SM Jr, Gladwin MT: Lactate dehydrogenase as a biomarker of hemolysis-associated nitric oxide resistance, priapism, leg ulceration, pulmonary hypertension, and death in patients with sickle cell disease. Blood 2006;107:2279-2285.
30. Hugel B, Socie G, Vu T, Toti F, Gluckman E, Freyssinet JM, Scrobohaci ML: Elevated levels of circulating procoagulant microparticles in patients with paroxysmal nocturnal hemoglobinuria and aplastic anemia. Blood 1999;93:3451-3456.
31. Simak J, Holada K, Risitano AM, Zivny JH, Young NS, Vostal JG: Elevated circulating endothelial membrane microparticles in paroxysmal nocturnal haemoglobinuria. Br J Haematol 2004;125:804-813.
32. Kozuma Y, Sawahata Y, Takei Y, Chiba S, Ninomiya H: Procoagulant properties of microparticles released from red blood cells in paroxysmal nocturnal haemoglobinuria. Br J Haematol 2011;152:631-639.
33. Whitlow M, Iida K, Marshall P, Silber R, Nussenzweig V: Cells lacking glycan phosphatidylinositol-linked proteins have impaired ability to vesiculate. Blood 1993;81:510-516.
34. Rank A, Nieuwland R, Toth B, Pihusch V, Delker R, Hiller E, Kolb HJ, Pihusch R: Microparticles for diagnosis of graft-versus-host disease after allo geneic stem transplantation. Transplantation 2011;92:244-250.
35. Nantakomol D, Dondorp AM, Krudsood S, Udomsangpetch R, Pattanapanyasat K, Combes V, Grau GE, White NJ, Viriyavejakul P, Day NP, Chotivanich K: Circulating red cell-derived microparticles in human malaria. J Infect Dis 2011; 203:700-706.
36. Omodeo-Sale F, Monti D, Olliaro P, Taramelli D: Prooxidant activity of betahematin (synthetic malaria pigment) in arachidonic acid micelles and phospholipid large unilamellar vesicles. Biochem Pharmacol 2001;61:999-1009.
37. Rubin O, Crettaz D, Tissot JD, Lion N: Pre-analytical and methodological challenges in red blood cell microparticle proteomics. Talanta 2010;82:1-8.
38. Jy W, Horstman LL, Jimenez JJ, Ahn YS: Measuring circulating cell-derived microparticles. J Thromb Haemost 2004;2:1842-1851.
39. Kini RM: Structure-function relationships and mechanism of anticoagulant phospholipase a(2) enzymes from snake venoms. Toxicon 2005;45:1147-1161.
40. Sinauridze EI, Kireev DA, Popenko NY, Pichugin AV, Panteleev MA, Kryms kaya OV, Ataullakhanov FI: Platelet microparticle membranes have 50-to 100-fold higher specific procoagulant activity than activated platelets. Thromb Haemost 2007;97:425-434.
41. Furie B, Furie BC: Mechanisms of disease: mechanisms of thrombus formation. N Engl J Med 2008;359:938-949.
42. Chung SM, Bae ON, Lim KM, Noh JY, Lee MY, Jung YS, Chung JH: Lysophosphatidic acid induces thrombogenic activity through phosphatidylserine exposure and procoagulant microvesicle generation in human erythrocytes. Arterioscler Thromb Vasc Biol 2007;27:414-421.
43. Lacroix R, Robert S, Poncelet P, Kasthuri RS, Key NS, Dignat-George F, Workshop IS: Standardization of platelet-derived microparticle enumeration by flow cytometry with calibrated beads: results of the International Society on Thrombosis and Haemostasis SSC Collaborative workshop. J Thromb Haemost 2010; 8:2571-2574.
44. Sadallah S, Eken C, Schifferli JA: Ectosomes as modulators of inflammation and immunity. Clin Exp Immunol 2011;163:26-32.
45. Sadallah S, Eken C, Schifferli JA: Erythrocyte-derived ectosomes have immunosuppressive properties. J Leukoc Biol 2008;84:1316-1325.